Correlation Between Rigel Pharmaceuticals and Oxford Cannabinoid
Can any of the company-specific risk be diversified away by investing in both Rigel Pharmaceuticals and Oxford Cannabinoid at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rigel Pharmaceuticals and Oxford Cannabinoid into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rigel Pharmaceuticals and Oxford Cannabinoid Technologies, you can compare the effects of market volatilities on Rigel Pharmaceuticals and Oxford Cannabinoid and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rigel Pharmaceuticals with a short position of Oxford Cannabinoid. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rigel Pharmaceuticals and Oxford Cannabinoid.
Diversification Opportunities for Rigel Pharmaceuticals and Oxford Cannabinoid
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Rigel and Oxford is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Rigel Pharmaceuticals and Oxford Cannabinoid Technologie in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oxford Cannabinoid and Rigel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rigel Pharmaceuticals are associated (or correlated) with Oxford Cannabinoid. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oxford Cannabinoid has no effect on the direction of Rigel Pharmaceuticals i.e., Rigel Pharmaceuticals and Oxford Cannabinoid go up and down completely randomly.
Pair Corralation between Rigel Pharmaceuticals and Oxford Cannabinoid
Given the investment horizon of 90 days Rigel Pharmaceuticals is expected to generate 7.36 times less return on investment than Oxford Cannabinoid. But when comparing it to its historical volatility, Rigel Pharmaceuticals is 10.03 times less risky than Oxford Cannabinoid. It trades about 0.08 of its potential returns per unit of risk. Oxford Cannabinoid Technologies is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 0.58 in Oxford Cannabinoid Technologies on September 1, 2024 and sell it today you would lose (0.30) from holding Oxford Cannabinoid Technologies or give up 51.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rigel Pharmaceuticals vs. Oxford Cannabinoid Technologie
Performance |
| Timeline |
| Rigel Pharmaceuticals |
| Oxford Cannabinoid |
Rigel Pharmaceuticals and Oxford Cannabinoid Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rigel Pharmaceuticals and Oxford Cannabinoid
The main advantage of trading using opposite Rigel Pharmaceuticals and Oxford Cannabinoid positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rigel Pharmaceuticals position performs unexpectedly, Oxford Cannabinoid can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oxford Cannabinoid will offset losses from the drop in Oxford Cannabinoid's long position.| Rigel Pharmaceuticals vs. Fortress Biotech | Rigel Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Rigel Pharmaceuticals vs. Pieris Pharmaceuticals | Rigel Pharmaceuticals vs. Cidara Therapeutics |
| Oxford Cannabinoid vs. Rigel Pharmaceuticals | Oxford Cannabinoid vs. Geron | Oxford Cannabinoid vs. Verastem | Oxford Cannabinoid vs. Immutep Ltd ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |